NCT06977841 - Tegoprazan-Based Dual Therapy With Amoxicillin vs Tetracycline for H. Pylori Eradication | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

May 30, 2026

Conditions

Helicobacter Pylori EradicationHigh-dose Dual Therapy

Interventions

DRUG

Tegoprazan

50 mg twice daily (BID), d1-14, administered 30 minutes before morning and evening meals.

DRUG

Amoxicillin 250Mg Cap

750 mg four times daily (QID), d1-14, administered immediately after breakfast, lunch, dinner, and bedtime snack.

DRUG

Tetracycline 500 Mg

500 mg three times daily (TID), d1-14, postprandial after breakfast, lunch, and dinner.

DRUG

Bismuth

220 mg BID, d1-14, administered 2-3 hours after tetracycline doses at lunch and dinner

Trial Locations (1)

RECRUITING

Zhongshan Hospital (Xiamen), Fudan University, Xiamen

All Listed Sponsors

lead

Zhongshan Hospital (Xiamen), Fudan University

OTHER